We have earlier shown that 65.8% of patients with T2D have a high 10 year predicted ASCVD risk16 as determined with the Pooled Cohorts Risks Equation and the current study has shown that 56.4% of our patients have elevated AIP. Here, AIP is linked to type 2 diabetes mellitus.